- Home
- OGI
as 11-15-2024 4:00pm EST
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
| Founded: | 2013 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 169.4M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 651.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.19 - $2.91 | Next Earning Date: | 12-17-2024 |
| Revenue: | $110,297,722 | Revenue Growth: | 2.33% |
| Revenue Growth (this year): | 8.76% | Revenue Growth (next year): | 14.04% |
Latest Organigram Holdings Inc. News
OGI Breaking Stock News: Dive into OGI Ticker-Specific Updates for Smart Investing
Market Exclusive
2 months ago
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Business Wire
2 months ago
Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment
Motley Fool
3 months ago
Organigram (OGI) Q3 2024 Earnings Call Transcript
Associated Press Finance
3 months ago
OrganiGram: Fiscal Q3 Earnings Snapshot
MT Newswires
3 months ago
Organigram Up 4.9% in U.S. Premarket After Q3 Profit Figures Released
Business Wire
3 months ago
Organigram Reports Third Quarter Fiscal 2024 Results
MT Newswires
3 months ago
Organigram Says Product Development Collaboration Completes Clinical Study on Nanoemulsion Technology
Business Wire
3 months ago
Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology
Compare OGI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OGI Organigram Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.